As merger and acquisition activity continues to grow in both volume and value, strategic and financial buyers are competing aggressively for investment opportunities on an unprecedented scale. In the health care industry, M&A transactions reached an all-time high in 2006, with $260.7 billion committed to finance 991 health care–related deals.
The Health Care M&A team at O’Melveny guides sophisticated companies and financial investors through the complexities of merging, acquiring, and disposing of health care businesses, whether public or private, domestic or international. In 2006, our clients entrusted us with more than 155 M&A transactions with an aggregate value of more than $90 billion. In 2007, we kicked off the year with our high-profile representation of CCMP Capital Advisors and Goldman Sachs Capital Partners in their attempted $6.4 billion acquisition of Triad Hospitals. Other M&A clients in the health-care sector include HCA Inc.; Merck & Co., Inc.; and CIGNA Corporation.
Key Facts
- Nightingale’s Healthcare News ranks O’Melveny 13th among the nation’s largest health care law practices.
- The 2006 Legal 500 recommends our London, Tokyo, and Hong Kong offices for M&A work, and spotlights the “high-profile deals” handled by our M&A lawyers in the United States.
- Thomson Financial ranked O’Melveny among the top 10 for European M&A deals with UK involvement (based on the first three quarters of 2006).
- Private Equity Analyst ranked our M&A practice fifth based on the number of private equity and venture capital deals we negotiated and closed in 2006.
- Corporate Control Alert ranked our M&A practice ninth for deals announced in 2006 valued at $100 million or more.
Industry Reach
We represent a variety of clients in all sectors of the health care and life sciences industries:
- Biotechnology companies
- Clinical laboratories
- Dialysis companies
- Health care Internet companies
- Health care services companies
- Health insurers and managed care organizations
- Home health agencies
- Hospitals and health care systems
- Investment banks
- Private equity, venture capital, and other investors
- Long-term care companies and assisted-living facilities
- Medical device manufacturers
- Medical supply manufacturers
- Pharmaceutical manufacturers